Clinical Trials on Moderate Hypertriacylglycerolemic Subjects in South Africa
Total 104 results
-
Microbiome Health Research InstituteUniversity of Cape TownTerminatedModerate Acute Malnutrition | Severe Acute MalnutritionSouth Africa
-
PfizerCompletedMild Hepatic Dysfunction | Moderate Hepatic DysfunctionSouth Africa
-
Alvotech Swiss AGCompletedHealthy Male SubjectsSouth Africa, Australia, New Zealand
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
Harokopio UniversityHellenic Republic Ministry of Development; Jotis S.A. Food IndustryCompletedHealthy Adult SubjectsGreece
-
NeuShen TherapeuticsRecruiting
-
Tavotek BiotherapeuticsActive, not recruiting
-
GlaxoSmithKlineCompleted
-
Auzone Biological Technology Pty LtdTIGERMED AUSTRALIA PTY LIMITED; CMAX Clinical Research Pty LtdCompleted
-
Haemonetics CorporationCompletedDOAC Eligible SubjectsUnited States
-
Trinomab Biotech Co., Ltd.TIGERMED AUSTRALIA PTY LIMITEDCompletedHealthy Adult SubjectsAustralia
-
Protagonist Therapeutics, Inc.Completed
-
PfizerCompletedCardiac Surgery Subjects | Subjects Undergoing CABG and/or Cardiac Valve ReplacementUnited States
-
PfizerCompletedHealthy | Otherwise Healthy Volunteers With Mild or Moderate Hepatic DysfunctionUnited States
-
GlaxoSmithKlineCompletedHealthy Subjects | AnaemiaAustralia
-
Hoffmann-La RocheCompleted
-
Edwards LifesciencesActive, not recruiting
-
Institut PasteurInstitut Pasteur de Madagascar; Action Contre la Faim; Centre de Recherches Médicales... and other collaboratorsCompletedModerate Acute MalnutritionCentral African Republic, Madagascar, Niger, Senegal
-
University of South CarolinaU.S. Army Medical Research and Development CommandCompletedSeaweed Associated Changes in Healthy SubjectsUnited States
-
PfizerTerminatedModerate-severe PainUnited States
-
University of SheffieldCompletedLong-term Physical Health Conditions | Mild to Moderate Anxiety and/or DepressionUnited Kingdom
-
GlaxoSmithKlineCompletedAtherosclerosis | Healthy SubjectsAustralia
-
GlaxoSmithKlineCompletedHealthy Subjects | Infections, BacterialAustralia
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
PfizerCompletedHealthy SubjectsUnited States
-
Hospira, now a wholly owned subsidiary of PfizerCompletedMechanically Ventilated and Intubated SubjectsUnited States, Australia, Argentina, Brazil, New Zealand
-
Actinogen MedicalRecruitingAlzheimer Disease | Dementia, Mild | Dementia ModerateAustralia
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
AbbVieRecruiting
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
Bristol-Myers SquibbTerminatedPsoriasis, Moderate to SevereUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Ralph H. Johnson VA Medical CenterJHSPH Center for Clinical TrialsNot yet recruitingBehavioral Symptoms | Agitation,Psychomotor | Dementia Moderate | Dementia SevereUnited States
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Janssen Research & Development, LLCRecruitingModerate Plaque PsoriasisUnited States, Canada
-
Koneksa HealthCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
Debiopharm International SACompletedModerate Alzheimer's DiseaseAustralia, Canada, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingBipolar Disorder | Cannabis Use | Bipolar I Disorder | Cannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe | Bipolar II Disorder | Schizoaffective Disorder, Bipolar TypeUnited States
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain